Beacon TPD

Track the TPD clinical trial and drug landscape with Beacon TPD

What we cover

Beacon Targeted Protein Degradation (TPD) covers trial and drug records for clinical, preclinical, approved and discontinued therapeutics involved in targeted protein degradation. The database covers:

  • Bivalent Degraders
  • Monovalent Degraders
  • Proteasome Inhibitors
  • DUB Inhibitors
  • E1/E2/E3 Modulators
  • Other comparable modalities

How Beacon helps

Here are some examples of how Beacon TPD can accelerate your research programs:

  • Search for TPD drugs across all stages of development so you can stay on top of new approaches in drug design.
  • Drastically reduce manual research time with our database solution which allows you to rapidly assemble data for analysis based on targets, ligands, ligases and much more.
  • Real time updates to help you keep track of new players, new assets and entries into the clinic.

How Beacon TPD Works

Search the trial and drug landscape by targetligands and ligases alongside other search criteria to instantly extract the data points you need to conduct more complex analysis.

How we target the data

We house all publicly available sources of data updated within 24 – 48 hours of publication proactively.  Our sources cover (but are not limited to):

  • Clinical trials registries
  • Scientific journals and publications
  • Company reports and presentations
  • Press releases
  • Conference reports and abstracts
  • Government and regulatory organizations
  • Newspapers and other media
  • Patents

Related content

TPD Webinar 2021

Find out more

TPD Infographic 2021

Find out more

What our customers say

Beacon is a great database that people should pay attention to. It's much better than many of the more generic databases that try to capture all data about everything

Director
Top Biotech Company

Our TPD Expert

Sofia Rodriguez, MSc, is the lead research analyst for Beacon TPD.

Sign up to her weekly newsletter to uncover the latest insights into the TPD landscape using data from Beacon Targeted Therapies.

Subscribe to newsletter

Other Beacon Solutions

ADC
Adoptive Cell
Bispecific
Cancer Vaccine
Checkpoint
Cytokine
DDR
Gene Therapy
RNA
Oncolytic Viruses
Beacon ADC Logo

 

Covering all Antibody Drug Conjugates (ADCs), Small Molecule Drug Conjugates (SMDCs), Protein Drug Conjugates (PDCs), Immunotoxins and more

Find out more

>

Beacon Adoptive Cell Logo

 

Covering all engineered and non-engineered immune cell therapies, including CAR-T, TCR, NK, TILs, Gamma-Delta T Cells and more

Find out more

Beacon Bispecific Logo

 

Covering all Bi- and Multi-Specific Antibodies, Antibody Fragments, Augmented Antibodies and more

Find out more

Cancer Vaccine Logo 2021

 

Beacon Cancer Vaccine provides the solution you need to master the prophylactic and therapeutic cancer vaccines field.

Find out more

Beacon Checkpoint Logo

 

Covering all Immune Checkpoint Combination Trials and Immune Checkpoint Modulators in development across 27 different checkpoint targets

Find out more

 

Covering all cytokines and drugs that target a cytokine or its immediate receptor belonging to the Interleukins, Interferons, Colony-stimulating factors, Transforming growth factor β, Tumour necrosis factor and Chemokines families.

Find out more

Beacon DDR Logo

 

Beacon DDR steps into the field to give drug developers the precise detailed view and broader picture of what is truly happening in the DDR field.

Find out more

Beacon Gene Therapy Logo

 

From gene-editing technologies, novel delivery systems, and a variety of genetic materials being used- Beacon Gene Therapy steps into the field to give drug developers a precise and detailed view of how the gene therapy landscape looks.

Find out more

 

Covering Oligonucleotide-based, mRNA-Based, Ribozyme, and gRNA-Mediated Gene Editing therapies, as well as RNA-Targeted Small Molecules – Beacon RNA covers all disease indications and many modalities to provide a detailed landscape of the RNA space.

Find out more

Beacon Oncolytic Viruses Logo

 

From capturing viral family and strains to understanding any genetic modifications – Beacon Oncolytic Viruses steps into the field to give drug developers the precise detailed view and broader picture of what is truly happening in the Oncolytic Virus field.

Find out more

Any questions? Contact us

To learn more about how we can tailor Beacon TPD to help you, get in touch with our sales team

Bertie MacArthur

 

Bertie MacArthur

Account Manager

Contact the Team

About Beacon Targeted Therapies

We are a clinical trial and pipeline database solution, designed in partnership with pharmaceutical professionals. We track targeted therapies to provide accurate, in-depth and real-time information in the rapidly evolving landscape of drug development.

logo